AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32726268 — intervention group
Group type: EXPERIMENTAL
Intervention: Dalbavancin
Number of subjects: 2883
Study 32726268 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactate ≥4 mmol/L
Number of subjects: 2883
Study 32726268 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactate ≥7 mmol/L
Number of subjects: 2883
Study 32726268 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactate <4 mmol/L
Number of subjects: 2883
Study 35511718 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetazolamide (250 mg 3 times/day)
Number of subjects: 13
Study 35511718 — intervention group
Group type: COMPARATOR
Intervention: Placebo (3 times/day)
Number of subjects: 13
Study 35511718 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetazolamide
Number of subjects: 13
Study 32895056 — intervention group
Group type: EXPERIMENTAL
Intervention: Anticoagulation with bivalirudin intravenously with a target aPTT of 45-70 sec for three days
Number of subjects: 100
Study 32895056 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment with low-molecular-weight heparins/unfractionated heparin subcutaneously
Number of subjects: 100
Study 35815855 — intervention group
Group type: EXPERIMENTAL
Intervention: Active cTBS (n = 11)
Number of subjects: 19
Study 35815855 — intervention group
Group type: COMPARATOR
Intervention: Sham cTBS (n = 9)
Number of subjects: 19
Study 33421265 — intervention group
Group type: EXPERIMENTAL
Intervention: ET-GP ablation
Number of subjects: 67
Study 33421265 — intervention group
Group type: COMPARATOR
Intervention: PVI
Number of subjects: 67
Study 32457078 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 mcg methylcobalamin
Number of subjects: 720
Study 32457078 — intervention group
Group type: COMPARATOR
Intervention: 50 mcg (quasi control)
Number of subjects: 720
Study 35986460 — intervention group
Group type: EXPERIMENTAL
Intervention: Remin Pro Forte (3-month program of hydroxyapatite, fluoride, xylitol, ginger, curcuma-containing cream)
Number of subjects: 20
Study 35986460 — intervention group
Group type: COMPARATOR
Intervention: Remin Pro (3-month cream regimen including hydroxyapatite and fluoride, xylitol)
Number of subjects: 20
Study 33608405 — intervention group
Group type: EXPERIMENTAL
Intervention: Early closure strategy (between 30 and 40 days from rectal surgery)
Number of subjects: 28
Study 33608405 — intervention group
Group type: COMPARATOR
Intervention: Late closure strategy (after the end of adjuvant therapy)
Number of subjects: 28
Study 33608405 — intervention group
Group type: EXPERIMENTAL
Intervention: Early closure strategy
Number of subjects: 28
Study 33608405 — intervention group
Group type: COMPARATOR
Intervention: Late closure strategy
Number of subjects: 28
Study 33725262 — intervention group
Group type: EXPERIMENTAL
Intervention: Children born to mothers with connective tissue diseases (CTD)
Number of subjects: 299
Study 33725262 — intervention group
Group type: EXPERIMENTAL
Intervention: Children born to mothers with chronic arthritis
Number of subjects: 299
Study 33725262 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with neurodevelopmental disorders (ND)
Number of subjects: 299
Study 33725262 — intervention group
Group type: COMPARATOR
Intervention: Prenatal exposure to maternal autoantibodies or anti-rheumatic drugs
Number of subjects: 299
Study 34188630 — intervention group
Group type: EXPERIMENTAL
Intervention: McGrath video laryngoscope
Number of subjects: 30
Study 34188630 — intervention group
Group type: COMPARATOR
Intervention: C-MAC video laryngoscope
Number of subjects: 30
Study 32281113 — intervention group
Group type: EXPERIMENTAL
Intervention: Proximal corticosteroid injection (40 mg of methylprednisolone injected 2 cm proximal to the wrist crease)
Number of subjects: 131
Study 32281113 — intervention group
Group type: EXPERIMENTAL
Intervention: Distal corticosteroid injection (40 mg of methylprednisolone injected 2 to 3 cm distal to the wrist crease)
Number of subjects: 131
Study 32281113 — intervention group
Group type: EXPERIMENTAL
Intervention: Proximal corticosteroid injection
Number of subjects: 131
Study 32281113 — intervention group
Group type: EXPERIMENTAL
Intervention: Distal corticosteroid injection
Number of subjects: 131
Study 36305278 — intervention group
Group type: COMPARATOR
Intervention: Zumba (ZG)
Number of subjects: 107
Study 36305278 — intervention group
Group type: COMPARATOR
Intervention: Football (FG)
Number of subjects: 107
Study 33565243 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-power fractional CO2 laser combined with topical tranexamic acid (TXA) applied twice a day for 3 weeks, four times in total.
Number of subjects: 0
Study 33565243 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified what treatment was used).
Number of subjects: 0
Study 32379976 — intervention group
Group type: EXPERIMENTAL
Intervention: T'ai chi intervention (36-week program with varying class frequency)
Number of subjects: 18
Study 32073793 — intervention group
Group type: EXPERIMENTAL
Intervention: Basophil activation test
Number of subjects: 0
Study 32073793 — intervention group
Group type: COMPARATOR
Intervention: Double-blind, placebo-controlled food challenge test
Number of subjects: 0
Study 35064189 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet
Number of subjects: 0
Study 35064189 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet plus fecal microbiota transplantation (FMT)
Number of subjects: 0
Study 35064189 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 32424691 — intervention group
Group type: EXPERIMENTAL
Intervention: Dentifrice B (1.100 ppmF-NaF)
Number of subjects: 30
Study 32424691 — intervention group
Group type: EXPERIMENTAL
Intervention: Dentifrice A (containing no fluoride)
Number of subjects: 30
Study 32424691 — intervention group
Group type: COMPARATOR
Intervention: Control (distilled water)
Number of subjects: 30
Study 35259259 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivosidenib
Number of subjects: 0
Study 35259259 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32135451 — intervention group
Group type: EXPERIMENTAL
Intervention: NMT plus VCIs
Number of subjects: 60
Study 32135451 — intervention group
Group type: EXPERIMENTAL
Intervention: NMT
Number of subjects: 60
Study 32135451 — intervention group
Group type: COMPARATOR
Intervention: Sham
Number of subjects: 60
Study 34273556 — intervention group
Group type: EXPERIMENTAL
Intervention: verum IAF-tACS
Number of subjects: 84
Study 34273556 — intervention group
Group type: COMPARATOR
Intervention: sham IAF-tACS (placebo)
Number of subjects: 84
Study 32677452 — intervention group
Group type: EXPERIMENTAL
Intervention: Pemigatinib
Number of subjects: 0
Study 32677452 — intervention group
Group type: COMPARATOR
Intervention: Gemcitabine plus cisplatin
Number of subjects: 0
Study 33370551 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintaining high PAI scores (≥100 PAI at both examinations)
Number of subjects: 17613
Study 33370551 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing PAI scores over time (PAI score of zero at first examination and ≥100 at last examination)
Number of subjects: 17613
Study 33370551 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintaining high PAI score
Number of subjects: 17613
Study 33370551 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing PAI score over time
Number of subjects: 17613
Study 33673786 — intervention group
Group type: EXPERIMENTAL
Intervention: Freeze all strategy
Number of subjects: 10
Study 33673786 — intervention group
Group type: COMPARATOR
Intervention: Fresh embryo transfer
Number of subjects: 10
Study 33673786 — intervention group
Group type: EXPERIMENTAL
Intervention: Freeze all treatment
Number of subjects: 10
Study 32171760 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-amendment inclusion criteria requiring elevated natriuretic peptides (B-type natriuretic peptide ≥200 ng/l or N-terminal pro-B-type natriuretic peptide ≥800 ng/l)
Number of subjects: 5022
Study 32171760 — intervention group
Group type: COMPARATOR
Intervention: Rivaroxaban treatment
Number of subjects: 5022
Study 36507206 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic aspiration of the knee joint
Number of subjects: 120
Study 36094645 — intervention group
Group type: EXPERIMENTAL
Intervention: Donanemab (700 mg for the first 3 doses, then 1400 mg every 4 weeks for up to 72 weeks)
Number of subjects: 272
Study 36094645 — intervention group
Group type: EXPERIMENTAL
Intervention: Donanemab
Number of subjects: 272
Study 36070709 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower glycemic criteria
Number of subjects: 4061
Study 36070709 — intervention group
Group type: COMPARATOR
Intervention: Higher glycemic criteria
Number of subjects: 4061
Study 36070709 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment for gestational diabetes
Number of subjects: 4061
Study 34473823 — intervention group
Group type: EXPERIMENTAL
Intervention: Health promotion interventions targeting African American men; specific interventions not detailed.
Number of subjects: 0
Study 34473823 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally tailored health promotion efforts; specific interventions not detailed.
Number of subjects: 0
Study 34218485 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-family carer partnership intervention over 10 weeks (five sessions)
Number of subjects: 44
Study 34218485 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 44
Study 33083465 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (DEX)
Number of subjects: 80
Study 33083465 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 80
Study 33810868 — intervention group
Group type: EXPERIMENTAL
Intervention: Bicarbonate supplementation (7 days)
Number of subjects: 14
Study 33810868 — intervention group
Group type: COMPARATOR
Intervention: Sodium chloride control (7 days)
Number of subjects: 14
Study 32142725 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-port robotic surgery
Number of subjects: 100
Study 35718032 — intervention group
Group type: EXPERIMENTAL
Intervention: ZnO–NF1 (1.5 g/L photocatalyst)
Number of subjects: 0
Study 35718032 — intervention group
Group type: EXPERIMENTAL
Intervention: ZnO–NF2 (1.5 g/L photocatalyst)
Number of subjects: 0
Study 35718032 — intervention group
Group type: EXPERIMENTAL
Intervention: ZnO–NF2 (2 g/L photocatalyst)
Number of subjects: 0
Study 35718032 — intervention group
Group type: EXPERIMENTAL
Intervention: ZnO–NF1
Number of subjects: 0
Study 35718032 — intervention group
Group type: EXPERIMENTAL
Intervention: ZnO–NF2
Number of subjects: 0
Study 34639439 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile mindfulness intervention
Number of subjects: 123
Study 34639439 — intervention group
Group type: COMPARATOR
Intervention: Online recruitment
Number of subjects: 123
Study 34639439 — intervention group
Group type: COMPARATOR
Intervention: Traditional recruitment
Number of subjects: 123
Study 35950470 — intervention group
Group type: EXPERIMENTAL
Intervention: tDCS and smart hand joint training device
Number of subjects: 60
Study 35950470 — intervention group
Group type: COMPARATOR
Intervention: Control group (smart hand joint training device)
Number of subjects: 60
Study 35950470 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (tDCS and smart hand joint training device)
Number of subjects: 60
Study 33302224 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth consultation
Number of subjects: 0
Study 33302224 — intervention group
Group type: COMPARATOR
Intervention: Face-to-face consultation (usual care)
Number of subjects: 0
Study 33302678 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed suction irrigation method
Number of subjects: 159
Study 33302678 — intervention group
Group type: COMPARATOR
Intervention: Conventional primary wound closure
Number of subjects: 159
Study 35416889 — intervention group
Group type: EXPERIMENTAL
Intervention: OMT combined with photobiomodulation (G1)
Number of subjects: 34
Study 35416889 — intervention group
Group type: COMPARATOR
Intervention: OMT combined with inactive laser (G2)
Number of subjects: 34
Study 32920065 — intervention group
Group type: EXPERIMENTAL
Intervention: Riboflavin (1.6 mg/d for 16 weeks)
Number of subjects: 80
Study 32920065 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 32865660 — intervention group
Group type: EXPERIMENTAL
Intervention: Sources of Strength (Sources) intervention in rural schools
Number of subjects: 20
Study 32865660 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group (non-intervention schools)
Number of subjects: 20
Study 34371324 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketadex (dexmedetomidine 0.7 μg/kg and ketamine 1 mg/kg)
Number of subjects: 93
Study 34371324 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketofol (propofol 0.5 mg/kg and ketamine 0.5 mg/kg)
Number of subjects: 93
Study 34371324 — intervention group
Group type: COMPARATOR
Intervention: Ketamine alone (1 mg/kg)
Number of subjects: 93
Study 34371324 — intervention group
Group type: COMPARATOR
Intervention: Ketadex vs Ketamine
Number of subjects: 93
Study 34371324 — intervention group
Group type: COMPARATOR
Intervention: Ketofol vs Ketamine
Number of subjects: 93
Study 34371324 — intervention group
Group type: COMPARATOR
Intervention: Ketamine
Number of subjects: 93
Study 32303810 — intervention group
Group type: EXPERIMENTAL
Intervention: Random training perturbation schedule
Number of subjects: 0
Study 32303810 — intervention group
Group type: EXPERIMENTAL
Intervention: Block training perturbation schedule
Number of subjects: 0
Study 32303810 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 33419899 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium hydroxide cement
Number of subjects: 384
Study 33419899 — intervention group
Group type: EXPERIMENTAL
Intervention: Mineral trioxide aggregate
Number of subjects: 384
Study 33419899 — intervention group
Group type: COMPARATOR
Intervention: Without liner
Number of subjects: 384
Study 33419899 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 384
Study 35227404 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional Socialization Training (EST)
Number of subjects: 80
Study 35227404 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Accommodation Modification (FAM)
Number of subjects: 80
Study 35227404 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined EST and FAM
Number of subjects: 80
Study 35227404 — intervention group
Group type: COMPARATOR
Intervention: Waitlist Control (WLC)
Number of subjects: 80
Study 32825989 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteopathic treatments (OTs)
Number of subjects: 82
Study 32825989 — intervention group
Group type: COMPARATOR
Intervention: Standard care (SC)
Number of subjects: 82
Study 36117146 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical gabapentin 10%
Number of subjects: 14
Study 36117146 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 32739607 — intervention group
Group type: EXPERIMENTAL
Intervention: Pneumatic Retinopexy (PnR)
Number of subjects: 388
Study 35310422 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg mirtazapine tablet
Number of subjects: 300
Study 35310422 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 mg dexamethasone diluted in 100 ml of saline infusion
Number of subjects: 300
Study 35310422 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study 33268401 — intervention group
Group type: EXPERIMENTAL
Intervention: Progestin-primed ovarian stimulation (PPOS) protocol
Number of subjects: 392
Study 33268401 — intervention group
Group type: COMPARATOR
Intervention: Flexible gonadotropin-releasing hormone (GnRH) antagonist protocol
Number of subjects: 392
Study 33268401 — intervention group
Group type: COMPARATOR
Intervention: Both PPOS and GnRH antagonist protocols
Number of subjects: 392
Study 34717820 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvoxamine (100 mg twice daily for 10 days)
Number of subjects: 1497
Study 34717820 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1497
Study 33757568 — intervention group
Group type: EXPERIMENTAL
Intervention: Active cycle of breathing techniques combined with phonophoresis
Number of subjects: 75
Study 33757568 — intervention group
Group type: COMPARATOR
Intervention: Active cycle of breathing techniques
Number of subjects: 75
Study 33757568 — intervention group
Group type: COMPARATOR
Intervention: Phonophoresis
Number of subjects: 75
Study 34058110 — intervention group
Group type: EXPERIMENTAL
Intervention: Biliopancreatic diversion
Number of subjects: 0
Study 34058110 — intervention group
Group type: COMPARATOR
Intervention: Medical and lifestyle therapy
Number of subjects: 0
Study 34911183 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualised counselling in addition to educational pamphlets
Number of subjects: 320
Study 34911183 — intervention group
Group type: COMPARATOR
Intervention: Educational pamphlets alone (Control)
Number of subjects: 320
Study 34911183 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualised counselling
Number of subjects: 320
Study 34911183 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall knowledge scores
Number of subjects: 320
Study 33497809 — intervention group
Group type: COMPARATOR
Intervention: Nesiritide
Number of subjects: 883
Study 33497809 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 883
Study 33497809 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline IL-6
Number of subjects: 883
Study 33497809 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-6 at 48-72 hours
Number of subjects: 883
Study 32828358 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral Parent Training (BPT)
Number of subjects: 58
Study 32828358 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 58
Study 36444919 — intervention group
Group type: COMPARATOR
Intervention: general information
Number of subjects: 735
Study 36444919 — intervention group
Group type: COMPARATOR
Intervention: option grid
Number of subjects: 735
Study 36444919 — intervention group
Group type: COMPARATOR
Intervention: option grid plus recommendation
Number of subjects: 735
Study 33452123 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril
Number of subjects: 603
Study 33452123 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 603
Study 35487475 — intervention group
Group type: EXPERIMENTAL
Intervention: Ca(OH)2 + saline solution (n = 10)
Number of subjects: 20
Study 35487475 — intervention group
Group type: EXPERIMENTAL
Intervention: Ca(OH)2 + 2% chlorhexidine-gel (n = 10)
Number of subjects: 20
Study 33649769 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-identified race
Number of subjects: 2944
Study 33649769 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive scores across racial groups
Number of subjects: 2944
Study 33649769 — intervention group
Group type: EXPERIMENTAL
Intervention: Proportion of African ancestry
Number of subjects: 2944
Study 32886337 — intervention group
Group type: EXPERIMENTAL
Intervention: Tretinoin 0.05% lotion
Number of subjects: 1640
Study 32886337 — intervention group
Group type: COMPARATOR
Intervention: Vehicle lotion (control)
Number of subjects: 1640
Study 35610603 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy APproach to weIght management and Food in Eating Disorders (HAPIFED)
Number of subjects: 98
Study 35610603 — intervention group
Group type: COMPARATOR
Intervention: Cognitive Behavioural Therapy‐ Enhanced (CBT‐E)
Number of subjects: 98
Study 33432016 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-administered survey on waste management awareness
Number of subjects: 2720
Study 34491428 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal cannula under the surgical mask
Number of subjects: 24
Study 34491428 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen mask under the surgical mask
Number of subjects: 24
Study 34491428 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen mask over the surgical mask
Number of subjects: 24
Study 34243076 — intervention group
Group type: EXPERIMENTAL
Intervention: Veliparib (120 mg orally BID) with carboplatin (AUC 6) and paclitaxel (80 mg/m2)
Number of subjects: 413
Study 34243076 — intervention group
Group type: COMPARATOR
Intervention: Placebo with carboplatin (AUC 6) and paclitaxel (80 mg/m2)
Number of subjects: 413
Study 34243076 — intervention group
Group type: EXPERIMENTAL
Intervention: Veliparib (300 mg BID, increasing to 400 mg BID if tolerated)
Number of subjects: 413
Study 34243076 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 413
Study 35681130 — intervention group
Group type: EXPERIMENTAL
Intervention: teen Mental Health First Aid (tMHFA)
Number of subjects: 1624
Study 35681130 — intervention group
Group type: COMPARATOR
Intervention: Physical first aid training (control)
Number of subjects: 1624
Study 32601853 — intervention group
Group type: EXPERIMENTAL
Intervention: Expressive writing group (n = 56)
Number of subjects: 112
Study 32601853 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged expressive writing group (n = 56)
Number of subjects: 112
Study 33836814 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-injection ultrasound-guided thoracic paravertebral block (US-TPVB) with 20 ml of 0.25% ropivacaine
Number of subjects: 88
Study 33836814 — intervention group
Group type: COMPARATOR
Intervention: Oblique subcostal transversus abdominis plane (TAP) block with 20 ml of 0.25% ropivacaine
Number of subjects: 88
Study 33836814 — intervention group
Group type: COMPARATOR
Intervention: Local anesthetic infiltration (LAI) with 40 ml of 0.25% ropivacaine
Number of subjects: 88
Study 33074110 — intervention group
Group type: EXPERIMENTAL
Intervention: Anulom Vilom Pranayama (AVP)
Number of subjects: 60
Study 33074110 — intervention group
Group type: EXPERIMENTAL
Intervention: Diaphragmatic Breathing Exercises (DBE)
Number of subjects: 60
Study 33074110 — intervention group
Group type: EXPERIMENTAL
Intervention: Kapal Bhati Pranayama (KBP)
Number of subjects: 60
Study 33074110 — intervention group
Group type: EXPERIMENTAL
Intervention: Pursed-Lip Breathing (PLB)
Number of subjects: 60
Study 36066078 — intervention group
Group type: EXPERIMENTAL
Intervention: Indacaterol (27.5 μg) plus glycopyrrolate (15.6 μg) twice daily for 12 weeks
Number of subjects: 535
Study 36066078 — intervention group
Group type: COMPARATOR
Intervention: Placebo twice daily for 12 weeks
Number of subjects: 535
Study 36066078 — intervention group
Group type: EXPERIMENTAL
Intervention: Indacaterol plus glycopyrrolate
Number of subjects: 535
Study 36066078 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 535
Study 33554616 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin
Number of subjects: 4401
Study 33554616 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4401